Monitoring ctDNA RAS Mutational Status in Metastatic Colorectal Cancer: A Trial Protocol of RAS-trace and RAS-trace-2 Studies

Background: Spatial and temporal heterogeneities of RAS and other molecular genes should be considered in the treatment of metastatic colorectal cancer (mCRC) treated with anti-epidermal growth factor receptor (EGFR) monoclonal antibodies (mAbs); acquired RAS mutation is sometimes observed at diseas...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Journal of the Anus, Rectum and Colon
المؤلفون الرئيسيون:	Kozo Kataoka, Takeshi Yamada, Manabu Shiozawa, Naoto Takase, Kazuma Ito, Kentaro Yamazaki, Jun Watanabe, Toshihiro Kudo, Takeshi Suto, Toshihiko Matsumoto, Kohei Murata, Yusuke Suwa, Shogen Boku, Hisateru Yasui, Nobuhisa Matsuhashi, Atsuyuki Maeda, Kiichi Sugimoto, Yusuke Matsumoto, Mitsuru Yokota, Johannes Fredebohm, Keita Mori, Masataka Ikeda
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	The Japan Society of Coloproctology 2024-04-01
الموضوعات:	colorectal cancer anti-egfr monoclonal antibody ras-trace ras-trace-2 ctdna
الوصول للمادة أونلاين:	https://www.jstage.jst.go.jp/article/jarc/8/2/8_2023-051/_pdf/-char/en